Health Care & Life Sciences » Biotechnology | Circassia Pharmaceuticals PLC

Circassia Pharmaceuticals PLC

Circassia Pharmaceuticals PLC
Stock Exchange London Stock Exchange
EPS
GBP0.34
Market Cap
GBP73.42 M
Shares Outstanding
375.14 M
Public Float
270.05 M

Profile

Address
Northbrook House
Oxford Oxfordshire OX4 4GA
United Kingdom
Employees -
Website http://circassia.com
Updated 07/08/2019
Circassia Pharmaceuticals Plc is a biopharmaceutical company, which engages in the development and commercialization of allergy, asthma, and respiratory products. It operates through the following segments: NIOX, Respiratory, and US AZ Collaboration. The NIOX segment provides a portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide.

Financials

View All

Francesco Granata
Chairman
Steven Charles Andrew Harris
Chief Executive Officer & Executive Director